Pacira BioSciences, Inc. PCRX Unrealized Losses on Investments (Before Tax)
Unrealized Losses on Investments (Before Tax) at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s unrealized losses on investments (before tax).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s unrealized losses on investments (before tax)?
- Pacira BioSciences, Inc. (PCRX) reported unrealized losses on investments (before tax) of $49K in Q1 2026.
- How has Pacira BioSciences, Inc.'s unrealized losses on investments (before tax) changed year-over-year?
- Pacira BioSciences, Inc.'s unrealized losses on investments (before tax) increased by 28.9% year-over-year, from $38K to $49K.
- What is the long-term trend for Pacira BioSciences, Inc.'s unrealized losses on investments (before tax)?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s unrealized losses on investments (before tax) has grown at a -16.0% compound annual growth rate (CAGR), from $31K to $13K.